Our findings also implied that, in the early stage of influenza virus infection (on the 10th day of infection), the proportions of CD4+ TM and CD8+ TM cells in BALF, lungs, and LN were significantly higher than those of the traditional TM, which are derived from approximately 10% of effector T cells after viral clearance. The gene discussed is CD4; the disease is infection.